Cargando…

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists

Many patients seen by cardiologists suffer chronic obstructive pulmonary disease (COPD) in addition to their primary cardiovascular problem. Yet, quite often COPD has not been diagnosed and, consequently, patients have not been treated of their pulmonary disease. Recognizing and treating COPD in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agusti, Alvar, Böhm, Michael, Celli, Bartolomé, Criner, Gerard J., Garcia-Alvarez, Ana, Martinez, Fernando, Sin, Don D., Vogelmeier, Claus F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215047/ https://www.ncbi.nlm.nih.gov/pubmed/37233751 http://dx.doi.org/10.1007/s00392-023-02217-0

Ejemplares similares

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
por: Agustí, Alvar, et al.
Publicado: (2023)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Gold 2023: Highlights for primary care
por: Agustí, Alvar, et al.
Publicado: (2023)

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
por: Celli, Bartolome, et al.
Publicado: (2017)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Highlights and hot topics in the management of COPD: where are we heading?
por: Agustí, Alvar, et al.
Publicado: (2016)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

GOLD 2023 Update: Implications for Clinical Practice
por: Tamondong-Lachica, Diana R, et al.
Publicado: (2023)

Reply to Thomson, to Neder et al., and to Wouters
por: Han, MeiLan K., et al.
Publicado: (2021)

Informe de la Barcelona-Boston Lung Conference 2021
por: Celli, Bartolomé, et al.
Publicado: (2021)

The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
por: Terry, Paul D., et al.
Publicado: (2023)

The EASI model: A first integrative computational approximation to the natural history of COPD
por: Agustí, Alvar, et al.
Publicado: (2017)

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022
por: Halpin, David M. G., et al.
Publicado: (2022)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond
por: Mall, Marcus A., et al.
Publicado: (2023)

Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
por: Celli, Bartolome R., et al.
Publicado: (2023)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Career perspectives for young cardiologists in the Netherlands: an update
por: Bosch, Lena, et al.
Publicado: (2023)

Recommendations for the early diagnosis of COPD: the AIMAR view
por: Celli, Bartolome R
Publicado: (2015)

Characterisation of COPD heterogeneity in the ECLIPSE cohort
por: Agusti, Alvar, et al.
Publicado: (2010)

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis
por: Vogelmeier, Claus, et al.
Publicado: (2016)

Systemic steroids in COPD-the beauty and the beast
por: Vogelmeier, Claus F
Publicado: (2014)

Venous Admixture in COPD: Pathophysiology and Therapeutic Approaches
por: Cooper, Christopher B., et al.
Publicado: (2009)

Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document
por: Suzuki, Toshio, et al.
Publicado: (2015)

Spotlight on Italian Association of Hospital Cardiologists (ANMCO) activity in the 2–year period 2021–2023
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
por: López-Campos, José Luis, et al.
Publicado: (2020)

It’s more than low BMI: prevalence of cachexia and associated mortality in COPD
por: McDonald, Merry-Lynn N., et al.
Publicado: (2019)

Selecting the Right Patient: The Achilles Heel of COPD Clinical Trials
por: Polverino, Francesca, et al.
Publicado: (2022)

Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study
por: Gunen, Hakan, et al.
Publicado: (2015)

Gold Nanoparticles Contact with Cancer Cell: A Brief Update
por: Bloise, Nora, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document
por: Bouza, Emilio, et al.
Publicado: (2020)

Morphea: The 2023 update
por: Papara, Cristian, et al.
Publicado: (2023)

Blutzuckerselbstkontrolle Update 2023
por: Wascher, Thomas C., et al.
Publicado: (2023)

Diabetestechnologie (Update 2023)
por: Schütz-Fuhrmann, Ingrid, et al.
Publicado: (2023)

Thrombozytenaggregationshemmer (Update 2023)
por: Wascher, Thomas C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6dav6q8mqg8i599dnefb1t4cm9